ASX:LCT Living Cell Technologies (LCT) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Living Cell Technologies Stock (ASX:LCT) 30 days 90 days 365 days Advanced Chart Get LCT alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolume76,622 shsAverage VolumeN/AMarket CapitalizationA$24.53 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Living Cell Technologies Limited, a biotechnology company, discovers, develops, and commercializes regenerative treatments that use naturally occurring cells to restore functions in Australia and New Zealand. It is developing NTCELL, an alginate-coated capsule, which is in phase IIb clinical trial for the treatment of Parkinson's disease. The company was founded in 1987 and is based in Melbourne, Australia. Read More Receive LCT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Living Cell Technologies and its competitors with MarketBeat's FREE daily newsletter. Email Address LCT Stock News HeadlinesUncovering how cells allocate space to make way for new growthJune 8, 2025 | msn.comCellVoyant's AI-Powered Vision for the Future of Cell TherapyApril 16, 2025 | msn.comThe #1 AI Energy StockNearly $600 billion is projected to be spent on AI data centers this year. That's because the ones being built now will dwarf everything that came before them. Thanks to AI's ravenous hunger for power … They are beginning to morph into sprawling behemoths.July 2 at 2:00 AM | Weiss Ratings (Ad)Super-resolution imaging technology reveals inner workings of living cellsApril 2, 2025 | msn.comMysterious stem cells: LCT procedure (3)December 29, 2024 | msn.comMolecular 'ZIP code' draws killer T cells to brain tumorsDecember 8, 2024 | msn.comNew 3D Bio-printer Injects Living Cells Directly Onto Injuries To Heal Bones and CartilageDecember 8, 2024 | msn.comResearchers use single-cell technologies and microfluidics to print organ structuresNovember 4, 2024 | msn.comSee More Headlines LCT Stock Analysis - Frequently Asked Questions How were Living Cell Technologies' earnings last quarter? Living Cell Technologies Limited (ASX:LCT) released its quarterly earnings results on Tuesday, February, 19th. The company reported $0.00 earnings per share (EPS) for the quarter. What other stocks do shareholders of Living Cell Technologies own? Based on aggregate information from My MarketBeat watchlists, some other companies that Living Cell Technologies investors own include eWellness Healthcare (EWLL), Energous (WATT), Cheniere Energy (LNG) and AllianceBernstein Global High Income Fund (AWF). Company Calendar Last Earnings2/19/2019Today7/02/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolASX:LCT CIKN/A Webwww.lctglobal.com Phone61 3 8689 9997FaxN/AEmployees147,000Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-A$2.11 million Net MarginsN/A Pretax MarginN/A Return on Equity-54.06% Return on Assets-18.67% Debt Debt-to-Equity RatioN/A Current Ratio9.35 Quick Ratio17.84 Sales & Book Value Annual SalesA$3.41 thousand Price / Sales0.00 Cash FlowN/A Price / Cash Flow2.17 Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares1,640,000,000Free FloatN/AMarket CapA$24.53 million OptionableNot Optionable Beta0.48 Reduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.Get This Free Report This page (ASX:LCT) was last updated on 7/2/2025 by MarketBeat.com Staff From Our Partners379 passengers walked away from thisElon Musk just wrote a $51 million check to back this material’s next phase… Because it’s not just saving l...True Market Insiders | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredForget Nvidia, This “Ghost Town” Company Holds the Key to the AI BoomCold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to...Brownstone Research | SponsoredIsrael-Iran WAR Could Destroy Trump's PresidencyThe missiles are already flying. Israel and Iran are now in direct military conflict — and this couldn't ha...American Alternative | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredThe #1 AI Energy StockNearly $600 billion is projected to be spent on AI data centers this year. That's because the ones being bu...Weiss Ratings | SponsoredTrump set to Boost Social Security Checks by 400%?If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Living Cell Technologies Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Living Cell Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
